293 related articles for article (PubMed ID: 20023176)
1. Transforming growth factor-beta modulates the expression of nitric oxide signaling enzymes in the injured developing lung and in vascular smooth muscle cells.
Bachiller PR; Nakanishi H; Roberts JD
Am J Physiol Lung Cell Mol Physiol; 2010 Mar; 298(3):L324-34. PubMed ID: 20023176
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
[TBL] [Abstract][Full Text] [Related]
3. Soluble guanylate cyclase modulates alveolarization in the newborn lung.
Bachiller PR; Cornog KH; Kato R; Buys ES; Roberts JD
Am J Physiol Lung Cell Mol Physiol; 2013 Oct; 305(8):L569-81. PubMed ID: 23934926
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-β downregulates sGC subunit expression in pulmonary artery smooth muscle cells via MEK and ERK signaling.
Du L; Roberts JD
Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L20-L34. PubMed ID: 30260287
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cGMP-dependent protein kinase expression by soluble guanylyl cyclase in vascular smooth muscle cells.
Browner NC; Dey NB; Bloch KD; Lincoln TM
J Biol Chem; 2004 Nov; 279(45):46631-6. PubMed ID: 15337747
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study.
Lee NP; Cheng CY
Endocrinology; 2003 Jul; 144(7):3114-29. PubMed ID: 12810568
[TBL] [Abstract][Full Text] [Related]
7. Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.
Crassous PA; Couloubaly S; Huang C; Zhou Z; Baskaran P; Kim DD; Papapetropoulos A; Fioramonti X; Durán WN; Beuve A
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H597-604. PubMed ID: 22730391
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing of cGMP-dependent protein kinase I in angiotensin-hypertension: novel mechanism for nitrate tolerance in vascular smooth muscle.
Gerzanich V; Ivanov A; Ivanova S; Yang JB; Zhou H; Dong Y; Simard JM
Circ Res; 2003 Oct; 93(9):805-12. PubMed ID: 14512447
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia decreases expression of soluble guanylate cyclase in cultured rat pulmonary artery smooth muscle cells.
Hassoun PM; Filippov G; Fogel M; Donaldson C; Kayyali US; Shimoda LA; Bloch KD
Am J Respir Cell Mol Biol; 2004 Jun; 30(6):908-13. PubMed ID: 14754757
[TBL] [Abstract][Full Text] [Related]
10. Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation.
Sayed N; Baskaran P; Ma X; van den Akker F; Beuve A
Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12312-7. PubMed ID: 17636120
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase.
Dunkern TR; Feurstein D; Rossi GA; Sabatini F; Hatzelmann A
Eur J Pharmacol; 2007 Oct; 572(1):12-22. PubMed ID: 17659276
[TBL] [Abstract][Full Text] [Related]
12. Sulfhydryl-dependent dimerization of soluble guanylyl cyclase modulates the relaxation of porcine pulmonary arteries to nitric oxide.
Ye L; Liu J; Liu H; Ying L; Dou D; Chen Z; Xu X; Raj JU; Gao Y
Pflugers Arch; 2013 Feb; 465(2):333-41. PubMed ID: 23143201
[TBL] [Abstract][Full Text] [Related]
13. Impaired iNOS-sGC-cGMP signalling contributes to chronic hypoxic and hypercapnic pulmonary hypertension in rat.
Xia XD; Xu ZJ; Hu XG; Wu CY; Dai YR; Yang L
Cell Biochem Funct; 2012 Jun; 30(4):279-85. PubMed ID: 22290599
[TBL] [Abstract][Full Text] [Related]
14. Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms.
Takata M; Filippov G; Liu H; Ichinose F; Janssens S; Bloch DB; Bloch KD
Am J Physiol Lung Cell Mol Physiol; 2001 Feb; 280(2):L272-8. PubMed ID: 11159006
[TBL] [Abstract][Full Text] [Related]
15. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
Zenzmaier C; Kern J; Heitz M; Plas E; Zwerschke W; Mattesich M; Sandner P; Berger P
Exp Cell Res; 2015 Nov; 338(2):162-9. PubMed ID: 26410556
[TBL] [Abstract][Full Text] [Related]
16. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
[TBL] [Abstract][Full Text] [Related]
17. H2O2 regulation of vascular function through sGC mRNA stabilization by HuR.
Martín-Garrido A; González-Ramos M; Griera M; Guijarro B; Cannata-Andia J; Rodriguez-Puyol D; Rodriguez-Puyol M; Saura M
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):567-73. PubMed ID: 21164076
[TBL] [Abstract][Full Text] [Related]
18. Molecular variants of soluble guanylyl cyclase affecting cardiovascular risk.
Wobst J; Rumpf PM; Dang TA; Segura-Puimedon M; Erdmann J; Schunkert H
Circ J; 2015; 79(3):463-9. PubMed ID: 25746521
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
Bouallegue A; Daou GB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
[TBL] [Abstract][Full Text] [Related]
20. Reduction in soluble guanylyl cyclase-specific activity following prolonged treatment of porcine pulmonary artery with nitric oxide.
Perkins WJ; Taniguchi M; Warner DO; Chini EN; Jones KA
Am J Physiol Lung Cell Mol Physiol; 2007 Jul; 293(1):L84-95. PubMed ID: 17384083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
